Alkem Laboratories Ltd, a major Indian pharmaceutical company, has come under scrutiny from both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) for discrepancies in their published data. Despite being listed on both exchanges, the company's auditor data, management team information and other corporate data do not match up, causing concern for investors and prompting a closer examination. This news serves as a reminder for investors to exercise caution and seek professional advice before making any investment decisions.